To view the PDF file, sign up for a MySharenet subscription.

AFROCENTRIC INVESTMENT CORP LIMITED - Dealings in securities by a director of major subsidiaries

Release Date: 02/06/2015 08:51
Code(s): ACT     PDF:  
Wrap Text
Dealings in securities by a director of major subsidiaries

AFROCENTRIC INVESTMENT CORPORATION LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT
ISIN: ZAE000078416
(“AfroCentric”)

DEALINGS IN SECURITIES BY A DIRECTOR OF MAJOR SUBSIDIARIES


In compliance with paragraph 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following
information is disclosed:

 Name of director:                          Mr KM Aron

 Status:                                    Chief Executive Officer of Medscheme Holdings Proprietary
                                            Limited and Executive Director of AfroCentric Health Limited,
                                            major subsidiaries of AfroCentric.

 Class of securities:                       Ordinary Shares

 Date of transaction:                       28 May 2015

 Price per share:                           R6.50

 Number of securities:                      28 899

 Total rand value of transaction:           R187 843.50

 Date of transaction:                       29 May 2015

 Price per share:                           R6.50

 Number of securities:                      13 539

 Total rand value of transaction:           R88 003.50

 Nature of transaction:                     Disposal of shares (On-market transaction)

 Nature of director’s interest:             Direct, beneficial

Clearance to deal was obtained in accordance with paragraph 3.66 of the Listings Requirements of the JSE
Limited.

2 June 2015

Sponsor
Sasfin Capital
(a division of Sasfin Bank Limited)

Date: 02/06/2015 08:51:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story